+86 27 8798 8585
| |

For Parents

You are at the location of:Home - For Parents - For Parents

Gardasil is the second such drug to gain access to patients across China

Article source:Station editor Update time:2018-05-28 14:53:42   Browsing times:second

Pharmaceutical company Merck recently won approval from the China Food and Drug Administration to sell its human papillomavirus vaccine, Gardasil, to help women fight cervical cancer.

Gardasil is expected to be commercially available on the mainland in three to six months, which means women will no longer have to seek vaccinations outside of the mainland, such as Hong Kong.
According to the Securities Times newspaper, Zhifei Biological Products Co in Chongqing will promote, supply and sell the vaccine in China for the next three years.
As the exclusive distributor of the vaccine, the company plans to purchase 1.14 billion yuan ($166 million) worth of Gardasil vaccines in the first year, 1.48 billion yuan in the second year and 1.85 billion yuan in the third year, the newspaper said.